Cholangiocarcinoma classification: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
==Classification== | ==Classification== | ||
*Cholangiocarcinoma may be classified according to location of the tumor into three subtypes:<ref name="pmid17457168">{{cite journal |vauthors=DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD |title=Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution |journal=Ann. Surg. |volume=245 |issue=5 |pages=755–62 |year=2007 |pmid=17457168 |pmc=1877058 |doi=10.1097/01.sla.0000251366.62632.d3 |url=}}</ref> | *Cholangiocarcinoma may be classified according to location of the tumor into three subtypes:<ref name="pmid17457168">{{cite journal |vauthors=DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD |title=Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution |journal=Ann. Surg. |volume=245 |issue=5 |pages=755–62 |year=2007 |pmid=17457168 |pmc=1877058 |doi=10.1097/01.sla.0000251366.62632.d3 |url=}}</ref> | ||
**Intrahepatic bile duct cancer | **[[Intrahepatic bile ducts|Intrahepatic bile duct]] cancer | ||
**Perihilar bile duct cancer | **Perihilar bile duct cancer | ||
**Extrahepatic bile duct cancer | **[[Extrahepatic bile ducts|Extrahepatic bile duct]] cancer | ||
===Cellular Classification of Cholangiocarcinoma=== | ===Cellular Classification of Cholangiocarcinoma=== | ||
'''Intrahepatic Bile Duct Cancer''' | '''Intrahepatic Bile Duct Cancer''' | ||
| Line 16: | Line 16: | ||
'''Perihilar Bile Duct Cancer''' | '''Perihilar Bile Duct Cancer''' | ||
*Carcinoma in situ | *[[Carcinoma]] in situ | ||
*Adenocarcinoma | *Adenocarcinoma | ||
:*Intestinal type | :*[[Intestinal]] type | ||
:*Mucinous type | :*[[Mucinous]] type | ||
:*Clear cell type | :*[[Clear cell tumor|Clear cell]] type | ||
*Signet-ring cell carcinoma | *Signet-ring cell carcinoma | ||
*Adenosquamous carcinoma | *Adenosquamous carcinoma | ||
*Squamous cell carcinoma | *[[Squamous cell]] carcinoma | ||
*Small cell (oat cell) carcinoma | *[[Small cell]] (oat cell) carcinoma | ||
*Undifferentiated carcinoma | *Undifferentiated carcinoma | ||
:*Spindle cell type | :*Spindle cell type | ||
:*Giant cell type | :*[[Giant cell]] type | ||
:*Small cell type | :*[[Small cell]] type | ||
*Papillomatosis | *[[Papillomatosis]] | ||
*Papillary carcinoma | *Papillary carcinoma | ||
:*Noninvasive | :*[[Noninvasive]] | ||
:*Invasive | :*[[Invasive]] | ||
*Carcinoma, NOS | *Carcinoma, NOS | ||
'''Extrahepatic Bile Duct Cancer''' | '''Extrahepatic Bile Duct Cancer''' | ||
*Carcinoma in situ | *Carcinoma in situ | ||
*Adenocarcinoma, not otherwise specified (NOS) | *[[Adenocarcinoma]], not otherwise specified (NOS) | ||
*Adenocarcinoma | *Adenocarcinoma | ||
:*Intestinal type | :*[[Intestinal]] type | ||
:*Mucinous type | :*Mucinous type | ||
:*Clear cell type | :*Clear cell type | ||
*Signet-ring cell carcinoma | *Signet-ring cell carcinoma | ||
*Adenosquamous carcinoma | *[[Adenosquamous carcinoma]] | ||
*Squamous cell carcinoma | *[[Squamous cell carcinoma]] | ||
*Small cell (oat cell) carcinoma | *[[Small cell]] (oat cell) carcinoma | ||
*Undifferentiated carcinoma | *Undifferentiated carcinoma | ||
:*Spindle cell type | :*[[Spindle cell]] type | ||
:*Giant cell type | :*[[Giant cell]] type | ||
:*Small cell type | :*[[Small cell]] type | ||
*Papillomatosis | *[[Papillomatosis]] | ||
*Papillary carcinoma | *Papillary carcinoma | ||
:*Noninvasive | :*Noninvasive | ||
*Papillary carcinoma | *Papillary carcinoma | ||
**Invasive | **[[Invasive]] | ||
| Line 62: | Line 62: | ||
*'''Type IIIA:''' Tumors involve the hepatic duct confluence and either the proximal right hepatic duct | *'''Type IIIA:''' Tumors involve the hepatic duct confluence and either the proximal right hepatic duct | ||
*'''Type IIIB:''' Tumors involve the hepatic duct confluence and either the proximal left hepatic duct | *'''Type IIIB:''' Tumors involve the hepatic duct confluence and either the proximal left hepatic duct | ||
*'''Type IV:''' Tumors extend into the bilateral proximal hepatic ducts up to the segmental bile ducts | *'''Type IV:''' Tumors extend into the [[bilateral]] proximal hepatic ducts up to the segmental bile ducts | ||
==References== | ==References== | ||
Revision as of 14:44, 6 February 2018
|
Cholangiocarcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangiocarcinoma classification On the Web |
|
American Roentgen Ray Society Images of Cholangiocarcinoma classification |
|
Risk calculators and risk factors for Cholangiocarcinoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Classification
- Cholangiocarcinoma may be classified according to location of the tumor into three subtypes:[1]
- Intrahepatic bile duct cancer
- Perihilar bile duct cancer
- Extrahepatic bile duct cancer
Cellular Classification of Cholangiocarcinoma
Intrahepatic Bile Duct Cancer
- Mass-forming tumor growth pattern
- Periductal-infiltrating tumor growth pattern
- Mixed mass-forming and periductal-infiltrating growth pattern
Perihilar Bile Duct Cancer
- Carcinoma in situ
- Adenocarcinoma
- Intestinal type
- Mucinous type
- Clear cell type
- Signet-ring cell carcinoma
- Adenosquamous carcinoma
- Squamous cell carcinoma
- Small cell (oat cell) carcinoma
- Undifferentiated carcinoma
- Spindle cell type
- Giant cell type
- Small cell type
- Papillomatosis
- Papillary carcinoma
- Carcinoma, NOS
Extrahepatic Bile Duct Cancer
- Carcinoma in situ
- Adenocarcinoma, not otherwise specified (NOS)
- Adenocarcinoma
- Intestinal type
- Mucinous type
- Clear cell type
- Signet-ring cell carcinoma
- Adenosquamous carcinoma
- Squamous cell carcinoma
- Small cell (oat cell) carcinoma
- Undifferentiated carcinoma
- Spindle cell type
- Giant cell type
- Small cell type
- Papillomatosis
- Papillary carcinoma
- Noninvasive
- Papillary carcinoma
Bismuth-Corlette classification
- Type I: Tumors are distal to the hepatic duct confluence
- Type II: Neoplasms extend to and involve the hepatic duct confluence
- Type IIIA: Tumors involve the hepatic duct confluence and either the proximal right hepatic duct
- Type IIIB: Tumors involve the hepatic duct confluence and either the proximal left hepatic duct
- Type IV: Tumors extend into the bilateral proximal hepatic ducts up to the segmental bile ducts
References
- ↑ DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD (2007). "Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution". Ann. Surg. 245 (5): 755–62. doi:10.1097/01.sla.0000251366.62632.d3. PMC 1877058. PMID 17457168.